Serum lipid concentrations in patients with comorbid generalized anxiety disorder and major depressive disorder

被引:57
作者
Sevincok, L
Buyukozturk, A
Dereboy, F
机构
[1] Adnan Menderes Univ, Fac Med, Dept Psychiat, Aydin, Turkey
[2] Adnan Menderes Univ, Fac Med, Dept Biochem, Aydin, Turkey
来源
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 2001年 / 46卷 / 01期
关键词
generalized anxiety disorder; major depression disorder; cholesterol; triglyceride; high-density lipoprotein cholesterol; low-density lipoprotein cholesterol;
D O I
10.1177/070674370104600110
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To examine the lipid levels in a sample of patients with comorbid generalized anxiety disorder (GAD) and major depressive disorder (MDD). Methods: Serum lipid concentrations were examined in 40 patients with both GAD and MDD, in 27 patients with MDD only, in 26 patients with GAD only and in 24 healthy control subjects. Results: A II mean serum cholesterol concentrations are presented in Table 1. The mean serum total cholesterol concentration in patients with both GAD and MDD was significantly higher than in MDD-only patients, GAD-only patients, and control subjects. The triglyceride concentration was also significantly, higher in patients with both GAD and MDD than in MDD-only patients, GAD-only patients, and control subjects. Patients with both GAD and MDD had a lower mean high-density lipoprotein cholesterol (HDL-C) concentration than did patients with GAD only and control subjects. The serum concentration of low-density lipoprotein cholesterol (LDL-C) was higher in patients with both GAD and MDD than in patients with MDD only and GAD only and healthy control subjects. Conclusions: Our findings indicate that the patients with both GAD and MDD have increased serum cholesterol, triglyceride, and LDL-C and reduced HDL-C levels. These patients may have a greater risk of mortality from coronary, artery disease (CAD) than do patients with either depression or anxiety disorder.
引用
收藏
页码:68 / 71
页数:4
相关论文
共 27 条
[1]   Low cholesterol level in patients with panic disorder:: the association with major depression [J].
Agargün, MY ;
Algün, E ;
Sekeroglu, R ;
Kara, H ;
Tarakçioglu, M .
JOURNAL OF AFFECTIVE DISORDERS, 1998, 50 (01) :29-32
[2]  
BAJWA WK, 1992, AM J PSYCHIAT, V149, P376
[3]   AN INVENTORY FOR MEASURING CLINICAL ANXIETY - PSYCHOMETRIC PROPERTIES [J].
BECK, AT ;
BROWN, G ;
EPSTEIN, N ;
STEER, RA .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1988, 56 (06) :893-897
[4]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[5]  
BRAY GA, 1978, INT J OBESITY, V2, P99
[6]   EATING ATTITUDES AND GLUCOSE-TOLERANCE IN ANOREXIA-NERVOSA PATIENTS AT 8-YEAR FOLLOW-UP COMPARED TO CONTROL SUBJECTS [J].
CASPER, RC ;
PANDEY, G ;
JASPAN, JB ;
RUBENSTEIN, AH .
PSYCHIATRY RESEARCH, 1988, 25 (03) :283-299
[7]  
Castelli WP, 1986, JAMA-J AM MED ASSOC, V249, P747
[8]   NEUROBIOLOGICAL MECHANISMS IN HUMAN ANXIETY - EVIDENCE SUPPORTING CENTRAL NORADRENERGIC HYPERACTIVITY [J].
CHARNEY, DS ;
REDMOND, DE .
NEUROPHARMACOLOGY, 1983, 22 (12B) :1531-1536
[9]   VARIABILITY OF PLASMA-LIPIDS IN RESPONSE TO EMOTIONAL AROUSAL [J].
DIMSDALE, JE ;
HERD, JA .
PSYCHOSOMATIC MEDICINE, 1982, 44 (05) :413-430
[10]   Cardiovascular risk factors in depression - The role of anxiety and anger [J].
Fava, M ;
Abraham, M ;
Pava, J ;
Shuster, J ;
Rosenbaum, J .
PSYCHOSOMATICS, 1996, 37 (01) :31-37